从患者角度看2019冠状病毒病对慢性阻塞性肺疾病和哮喘住院情况的影响以及疫情
Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient's perspective.
作者信息
Sykes Dominic L, Faruqi Shoaib, Holdsworth Luke, Crooks Michael G
机构信息
Respiratory Research Group, Hull University Teaching Hospitals, Hull, UK.
出版信息
ERJ Open Res. 2021 Feb 8;7(1). doi: 10.1183/23120541.00822-2020. eCollection 2021 Jan.
Abstract
摘要
https://bit.ly/2Kv0O0H. （链接无法直接翻译出具体含义，保留原文链接形式）
相似文献
1
Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient's perspective.从患者角度看2019冠状病毒病对慢性阻塞性肺疾病和哮喘住院情况的影响以及疫情
ERJ Open Res. 2021 Feb 8;7(1). doi: 10.1183/23120541.00822-2020. eCollection 2021 Jan.
2
Respiratory admissions before and during the COVID-19 pandemic with mediation analysis of air pollutants, mask-wearing and influenza rates.新冠疫情前后呼吸系统疾病住院人数与空气污染物、口罩佩戴率和流感发病率的中介分析。
Respirology. 2023 Jan;28(1):47-55. doi: 10.1111/resp.14345. Epub 2022 Aug 10.
3
Hospital Admission Rates in Patients with COPD Throughout the COVID-19 Pandemic.COPD 患者在整个 COVID-19 大流行期间的住院率。
Int J Chron Obstruct Pulmon Dis. 2023 Aug 17;18:1763-1772. doi: 10.2147/COPD.S409452. eCollection 2023.
4
Examining the effect of the COVID-19 pandemic on community virus prevalence and healthcare utilisation reveals that peaks in asthma, COPD and respiratory tract infection occur with the re-emergence of rhino/enterovirus.研究 COVID-19 大流行对社区病毒流行和医疗保健利用的影响表明，随着鼻病毒/肠道病毒的再次出现，哮喘、COPD 和呼吸道感染的高峰期出现。
Thorax. 2023 Dec;78(12):1248-1253. doi: 10.1136/thorax-2022-219957. Epub 2023 Jul 9.
5
Air quality in Mexico City during the COVID-19 lockdown possibly decreased COPD exacerbations.在新冠疫情封锁期间，墨西哥城的空气质量可能降低了慢性阻塞性肺疾病（COPD）的急性加重发生率。
ERJ Open Res. 2022 Oct 10;8(4). doi: 10.1183/23120541.00183-2022. eCollection 2022 Oct.
6
Post-pandemic seasonal dynamics of hospitalised COPD exacerbations and aetiologies in the COPD population.慢性阻塞性肺疾病（COPD）患者中住院的COPD急性加重及病因的大流行后季节性动态变化
ERJ Open Res. 2024 Sep 30;10(5). doi: 10.1183/23120541.00258-2024. eCollection 2024 Sep.
7
Asthma Patients Benefit More Than Chronic Obstructive Pulmonary Disease Patients in the Coronavirus Disease 2019 Pandemic.在2019冠状病毒病大流行中，哮喘患者比慢性阻塞性肺疾病患者受益更多。
Front Med (Lausanne). 2021 Sep 10;8:709006. doi: 10.3389/fmed.2021.709006. eCollection 2021.
8
The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown?英国首次新冠疫情高峰对重度哮喘患者的影响。哪个更糟糕：病毒还是封锁措施？
ERJ Open Res. 2021 Feb 1;7(1). doi: 10.1183/23120541.00768-2020. eCollection 2021 Jan.
9
Impact of COVID-19 Pandemic on the Exacerbation Rates in COPD Patients in Southern India - A Potential Role for Community Mitigations Measures.新冠疫情对印度南部 COPD 患者恶化率的影响-社区缓解措施的潜在作用。
Int J Chron Obstruct Pulmon Dis. 2023 Aug 29;18:1909-1917. doi: 10.2147/COPD.S412268. eCollection 2023.
10
Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience.吸入性糖皮质激素与哮喘患者的 COVID-19 结局：以色列的经验
ERJ Open Res. 2022 Mar 7;8(1). doi: 10.1183/23120541.00014-2022. eCollection 2022 Jan.
引用本文的文献
1
Impact of COVID-19 and lockdown on outcomes of COPD patients in Turkey: lessons for the future.COVID-19与封锁措施对土耳其慢性阻塞性肺疾病患者治疗结果的影响：对未来的启示
BMC Pulm Med. 2025 Aug 30;25(1):414. doi: 10.1186/s12890-025-03883-8.
2
Age-Related Variations and Seasonal Influences: A Network Analysis of Comorbidities in Asthma Hospitalizations (2013-2023).年龄相关差异和季节影响：2013 - 2023年哮喘住院合并症的网络分析
J Clin Med. 2025 Mar 29;14(7):2350. doi: 10.3390/jcm14072350.
3
Exploring Psychological Trends in Populations With Chronic Obstructive Pulmonary Disease During COVID-19 and Beyond: Large-Scale Longitudinal Twitter Mining Study.探索2019年冠状病毒病期间及之后慢性阻塞性肺疾病患者群体的心理趋势：大规模纵向推特挖掘研究
J Med Internet Res. 2025 Mar 5;27:e54543. doi: 10.2196/54543.
4
Modifiable risk factors for asthma exacerbations during the COVID-19 pandemic: a population-based repeated cross-sectional study using the Research and Surveillance Centre primary care database.2019冠状病毒病大流行期间哮喘急性加重的可改变风险因素：一项基于人群的重复横断面研究，使用研究与监测中心初级保健数据库
Lancet Reg Health Eur. 2024 May 24;42:100938. doi: 10.1016/j.lanepe.2024.100938. eCollection 2024 Jul.
5
Chronic Obstructive Pulmonary Disease Mortality and Hospitalization during the COVID-19 Pandemic Compared with before the Pandemic: A Systematic Review and Meta-Analysis.与大流行前相比，COVID-19大流行期间慢性阻塞性肺疾病的死亡率和住院率：一项系统评价和荟萃分析。
J Pers Med. 2024 Mar 10;14(3):296. doi: 10.3390/jpm14030296.
6
Impact of the COVID-19 Pandemic on COPD Patient Mortality: A Nationwide Study in France.COVID-19 大流行对 COPD 患者死亡率的影响：法国全国性研究。
Int J Public Health. 2024 Feb 1;69:1606617. doi: 10.3389/ijph.2024.1606617. eCollection 2024.
7
Impacts of ambient air quality on acute asthma hospital admissions during the COVID-19 pandemic in Oxford City, UK: a time-series study.大气空气质量对英国牛津市 COVID-19 大流行期间急性哮喘住院的影响：一项时间序列研究。
BMJ Open. 2024 Jan 23;14(1):e070704. doi: 10.1136/bmjopen-2022-070704.
8
Acute presentations of eating disorders among adolescents and adults before and during the COVID-19 pandemic in Ontario, Canada.加拿大安大略省青少年和成年人在 COVID-19 大流行之前和期间进食障碍的急性发作。
CMAJ. 2023 Oct 3;195(38):E1291-E1299. doi: 10.1503/cmaj.221318.
9
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.在英国，COPD 患者在加重后立即使用单一吸入氟替卡松糠酸酯、乌美溴铵和维兰特罗（FF/UMEC/VI）的益处：一项回顾性队列研究。
Respir Res. 2023 Sep 25;24(1):229. doi: 10.1186/s12931-023-02523-1.
10
Impact of Coronavirus Disease 2019 on Hospital Admissions, Health Status, and Behavioral Changes of Patients with COPD.2019冠状病毒病对慢性阻塞性肺疾病患者住院情况、健康状况及行为变化的影响
Chronic Obstr Pulm Dis. 2023 Jul 26;10(3):211-223. doi: 10.15326/jcopdf.2022.0383.
本文引用的文献
1
The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown?英国首次新冠疫情高峰对重度哮喘患者的影响。哪个更糟糕：病毒还是封锁措施？
ERJ Open Res. 2021 Feb 1;7(1). doi: 10.1183/23120541.00768-2020. eCollection 2021 Jan.
2
COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD.新冠疫情期间的慢性阻塞性肺疾病：慢性阻塞性肺疾病患者急性加重情况及报告的行为变化分析
ERJ Open Res. 2021 Jan 18;7(1). doi: 10.1183/23120541.00718-2020. eCollection 2021 Jan.
3
Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic.在 2019 冠状病毒病疫情期间，香港因慢性阻塞性肺疾病急性加重而住院的人数显著减少。
Respir Med. 2020 Sep;171:106085. doi: 10.1016/j.rmed.2020.106085. Epub 2020 Jul 12.
4
Disproportionate decline in admissions for exacerbated COPD during the COVID-19 pandemic.在新冠疫情期间，慢性阻塞性肺疾病急性加重患者入院人数的下降比例失调。
Respir Med. 2022 Jan;191:106120. doi: 10.1016/j.rmed.2020.106120. Epub 2020 Aug 14.
5
Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population.新冠疫情之前及期间的心理健康状况：一项针对英国人群的纵向概率抽样调查
Lancet Psychiatry. 2020 Oct;7(10):883-892. doi: 10.1016/S2215-0366(20)30308-4. Epub 2020 Jul 21.
6
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
7
Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges.慢性阻塞性肺疾病与新冠疫情：相互挑战
Respir Med Res. 2020 Nov;78:100764. doi: 10.1016/j.resmer.2020.100764. Epub 2020 May 11.
8
Sedentary Behavior Is an Independent Predictor of Mortality in Subjects With COPD.久坐行为是慢性阻塞性肺疾病患者死亡率的独立预测因素。
Respir Care. 2017 May;62(5):579-587. doi: 10.4187/respcare.05306. Epub 2017 Mar 7.
9
Depression and anxiety in patients with COPD.慢性阻塞性肺疾病患者的抑郁和焦虑
Eur Respir Rev. 2014 Sep;23(133):345-9. doi: 10.1183/09059180.00007813.
10
Pulmonary rehabilitation and the BODE index in COPD.慢性阻塞性肺疾病中的肺康复与BODE指数
Eur Respir J. 2005 Oct;26(4):630-6. doi: 10.1183/09031936.05.00045505.
Zotero 插件